Overview

Influence of Chemotherapy on Gamma-delta T Cells in Patients With Epithelial Ovarian Cancer

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
In patients with an ovarian cancer, the treatment is currently based on surgery and chemotherapy. The impact of chemotherapy on the expansion and functional abilities of Vgamma9Vdelta2 T cells has never been evaluated. The long term goal is to give a rational to combine conventional treatment of ovarian cancer with immunotherapy based on Vgamma9Vdelta2 T cells.
Details
Lead Sponsor:
Rennes University Hospital
Treatments:
Carboplatin
Paclitaxel